Navigation Links
Endocrinologists and surgeons join forces to fight type 2 diabetes
Date:8/25/2008

New York (August 21, 2008) -- At the 1st World Congress for Interventional Therapies for Type 2 Diabetes, prominent endocrinologists from around the world will convene in an exchange with leading surgeons about the role of surgery and other emerging new therapies for type 2 diabetes.

Twenty-four of the most important Scientific Societies from the US and worldwide have endorsed the World Congress to encourage a responsible and timely discussion of all aspects of this emerging discipline, including its implications for public health and diabetes research.

"The American Association of Clinical Endocrinologists (AACE) is pleased to endorse the 1st World Congress on Interventional Therapies for Type 2 Diabetes" the Society said in a statement. "AACE recognizes the need for interventions that are proven to be safe and effective in the management of type 2 diabetes. AACE looks forward to participating in this very important scientific meeting, which will critically examine the potential role for surgery in treating type 2 diabetes and other related metabolic disorders."

"I am excited about the collaboration between endocrinologists and surgeons," said Dr. Louis Aronne clinical professor of medicine at Weill Cornell Medical College. "Together along with other leading experts in diabetes and public health, the Congress will examine the emerging role of surgery, not only as a therapy for type 2 diabetes, but as a means to shed light on the causes of the disease. The lessons we are already learning from studying gastrointestinal surgery have tremendous implications for the same future of medical therapies of diabetes."

Type 2 Diabetes affects an estimated 24 million Americans and 246 million people worldwide, a number that is expected to grow to 380 million by 2025. Faced with the escalating global diabetes crisis, health care providers require potent tools for therapeutic interventions. Various types of surgery on the gastrointestinal tract constitute extremely powerful options to help fight diabetes in patients with severe obesity. The appropriate role of surgery in the treatment of patients with type 2 diabetes has recently become a matter of intense scientific and public debate.

"Surgery has arrived like a comet across the firmament of diabetes and obesityunexpected, brilliant, with great promise for the future," said Dr. Jesse Roth, Congress faculty member, researcher, and diabetologist at the Feinstein Institute for Medical Research and the Albert Einstein College of Medicine of Yeshiva University in New York. "Teams of talented researchers are moving ahead to define the role of surgery in the treatment of both of these scourges."

Dr Francesco Rubino, Director of the World Congress and Chief of Metabolic Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, emphasized that surgery offers also a unique opportunity to improve knowledge of the mechanisms of diabetes. "Teasing out the agents responsible for the beneficial effects of gastrointestinal surgery on diabetes may lead to new discoveries and provide targets for new medications or even less invasive interventional therapies."


'/>"/>

Contact: John Rodgers
jdr2001@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals
2. Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus
3. AUDIO from Medialink, Eli Lilly and the American Association of Clinical Endocrinologists: Dont let Natural Disasters Leave you Without Needed Medications
4. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
5. Surgeons Remove Gallbladder Through Vagina
6. CRH Medical to exhibit at American College of Surgeons Annual Clinical Congress
7. Cosmetic Surgeons Gather in Dubai for World Congress, Hospital Opening
8. Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress
9. Patients should ask surgeons about using honey to heal wounds
10. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
11. Survey shows gender differences are factor when surgeons in training choose a subspecialty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... DESCO ... acquired Pocono Sterilizer, an equipment sterilization service and sales company located in Pennsylvania. ... medical and research-related equipment and asset management services to the medical and academic ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... their Vasont Universal Integrator (VUI) extension supports the latest release of Adobe FrameMaker, ... FrameMaker 2015 interlace the process of creating, editing and storing XML. ...
(Date:5/3/2016)... ... ... The National Association of Professional Women (NAPW) honors Barbara ... She is recognized with this prestigious distinction for leadership in business. NAPW is the ... over 200 operating Local Chapters. , “I’m pleased to welcome Barbara into this exceptional ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... Irvine, California (PRWEB) , ... May 03, 2016 ... ... of its innovative brainsalvation tool – a web application that helps people assess ... medical research, the brainsalvation™ web app will provide users a “Risk Reduction Score™” ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... May 2, 2016 Kalorama Information noted the ... Records) market in a recent white paper.  The healthcare ... physician usage, a growing market are among the top ... Kalorama,s report EMR 2016: The Market for ... seventh complete study of the EMR industry, and the ...
(Date:5/2/2016)... N.J. , May 2, 2016  Celsion ... development company, today announced data from the first ... escalating clinical trial (the OVATION Study) combining GEN-1, ... care for the treatment of newly-diagnosed patients with ... followed by interval debulking surgery.  In the first ...
(Date:4/29/2016)... , April 29, 2016 ... Life Sciences, Product Development Capabilities in ... Customer Base . Indegene ( ... announced the acquisition of Skura Corporation,s life science ... in adaptive sales enablement technology for life science ...
Breaking Medicine Technology: